| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.099 | 0.06 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.33 | 0.06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.06 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |